This webinar will shed light on all the sponsor’s responsibilities for an Active Investigational New Drug application (IND). Alongside this presentation would detail the each of the sponsor’s activity in greater detail including timelines to implement the same. What’s more; the discussion will also detail the safety reporting regulations and associated timelines.
Course Objectives:
• Understanding each and every Sponsor responsibility in greater detail helps mitigate any delays in the clinical study or minimize the chances of a clinical hold
• The webinar will help the sponsor, or the company understand the each of the processes (including new protocol, Protocol revisions, new investigator) as well as the information amendments and its associated timelines for seamless conduct of clinical study
• Learning the IND safety reporting Regulations, follow up reporting and timelines
• Insight into IND inactivation and withdrawal
Why Should You Attend:
It is important for the sponsor(s)/ Pharma companies to understand the every aspect of the Sponsor’s obligation once an active IND is in place for a clinical study. Understanding process and its associated timelines are critical in order for the sponsor to avoid or mitigate delays or risk of Clinical hold. Also critical is understanding the regulations around mandatory safety reporting.
Course Outline:
• Overview of the basic responsibilities of a sponsor of an Active IND
• Understanding each step and the associated process(es)s in greater detail along with timelines involved
• Protocol amendments (New protocols, protocol revisions, new investigator)
• Information amendments
• IND Safety reporting regulations and timelines
• Identification and options for resolution of the clinical hold
• Annual reports
• Inactivation of an IND, Withdrawal of an IND
• Some tips on the best practices to circumvent any delays or clinical hold
What You Get:
• Training Materials
• Live Q&A Session with our Expert
• Participation Certificate
• Access to Signup Community (Optional)
• Reward Points
Who Will Benefit:
• The following professionals or disciplines will benefit from attending this Webinar:
• Regulatory affairs professionals
• Senior management executives (CEO, COO, CFO, etc)
• Drug discovery and development professionals (R&D and CMC)
• Intellectual property experts
• Project Managers and Clinical trial specialists
• Regulatory Compliance Associates and Managers
• People investing in FDA-regulated product development projects
Adverse Event Reporting Understanding Regulatory Reporting Requirements
Get Instant Access 60 Minutes View Program |
Analyzing Assay Validation for Clinical Diagnostics
Get Instant Access 60 Minutes View Program |
Protocol Deviations: Documenting, Managing, and Reporting
Get Instant Access 60 Minutes View Program |
The Sunshine Act: Reporting for Clinical Trials
Get Instant Access 60 Minutes View Program |
The Secret of Study Conduct Documentation to ensure a successful Audit: What the FDA Inspectors looks for
Get Instant Access 90 Minutes View Program |
Get Instant Access On-Demand Access
Preparing for the ICE Storm: What to Do During I 9 Audits and ICE Raids
Janette S. Levey
Human Resources
Get Instant Access On-Demand Access
OSHA Inspections and Investigations-How to Manage Them
Irwin Dobrushin
Environment Health and Safety | OSHA
Get Instant Access On-Demand Access
29 CFR 1904: OSHA's New Injury Recordkeeping E-Submission Rule
Occupational Safety and Health Administration
Get Instant Access On-Demand Access
Working with Excel Databases: Sort, Filter, Subtotal and More
Cathy Horwitz
Cross Industry | Skill Enhancement
Get Instant Access On-Demand Access
Writing Audit Reports
Jonnie T. Keith CIA, CFE, CGAP, CICA
Governance, Risk and Compliance
Get Instant Access On-Demand Access
BSA Reporting Requirements
Banking and Financial Services Industry
Get Instant Access On-Demand Access
Human Factors-Usability Based on ISO 62366
Medical Device | Diagnostic | Pharmaceutical | Biologics fields
Get Instant Access On-Demand Access
Chat GPT for Project Managers
Charles H. Paul
All FDA Regulated Industry